Abstract

Cannabinoid Hyperemesis Syndrome (CHS) is a medical condition associated with daily long-term use of marijuana characterized by nausea, abdominal cramps, and cyclical vomiting which typically presents in the emergency department (ED) setting. There is currently no diagnostic or lab test for CHS. Diagnosis by exclusion is used to rule out other potential causes of vomiting and nausea. The purpose of this study was to understand the economic and procedural burden of CHS in the U.S. ED setting.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call